Navigation Links
Reportlinker Adds Future Directions in Regenerative Medicine
Date:5/26/2011

NEW YORK, May 26, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Future Directions in Regenerative Medicine

http://www.reportlinker.com/p0511976/Future-Directions-in-Regenerative-Medicine.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Biological_Therapy

Big Pharma has begun investing in regenerative medicine: Genzyme in 2008, Pfizer and Novartis in 2009, and Cephalon in 2010. In 3-5 years, investment will reach a "tipping point", after which no medical industry players will want to be left behind.

This report covers the development of therapies to replace human cells or promote their regeneration: including cell therapies, tissue engineering, drugs, and medical devices. Each company profiled has at least one project in preclinical or Phase I study. Many also have later stage or launched products, which are covered briefly to illustrate the potential of the next generation of candidates.

Scope of this research

• Understand the concepts behind regenerative medicine, its potential applications, and advantages over traditional medicine.

• Compare the opportunities and challenges presented by the different therapeutic modalities.

• Understand the hurdles that must be overcome by regenerative medicine candidates before they can successfully enter the market.

• Identify emerging technologies that will shape the regenerative medicine industry in the coming years.

• Identify companies that may be competitors for a market, or alternatively poten
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Reportlinker Adds Innovations in Protein Kinase Therapies - Significant Proportion of Protein Kinase Pipeline Contains Small Molecule Drugs That Target Oncology
2. Reportlinker Adds Technology Transfer Strategies - A Guide to Maximizing Returns Within the Pharmaceutical and Biopharmaceutical Industries
3. Reportlinker Adds Analytical Tool - Lymphoma
4. Reportlinker Adds Enzymes: Sustainable Alternatives with Remarkable Scope
5. Reportlinker Adds Industrial Biotechnology China News 1104
6. Reportlinker Adds Healthcare Information Technology
7. Reportlinker Adds Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines
8. Reportlinker Adds Global Biomaterial Market (2010 - 2015)
9. Reportlinker Adds Genetics Reports Bundle
10. Reportlinker Adds Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
11. Reportlinker Adds Biomarkers: Technologies and Global Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Massachusetts (PRWEB) October 22, 2014 ... announced the release of a new infographic, Understanding ... to create a beautifully designed, easy to follow informative ... transmission, areas of outbreak, symptoms and prevention. , "As ... discovered that the 2014 Ebola outbreak represents not only ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 Grace Century, ... and healthcare projects, announces the addition of Dr. ... to its advisory team. Dr. Siddiqui will provide further ... , A graduate of University College Medical School ... degreed in medicine in 2001. With further certification as ...
(Date:10/22/2014)... , Oct. 22, 2014   Synthetic Biologics, ... novel pathogen-specific therapies for serious infections and diseases, announced ... issued a Notice of Allowance for a composition of ... C. difficile program, SYN-004. This is Synthetic ... in the U.S. and adds to the Company,s extensive ...
(Date:10/22/2014)... Oct. 22, 2014 Research and Markets ... Market by Material, by Application, Geography - Global Analysis ... offering. Organic electronics, also called as ... material science which deals with small conductive molecules and ... small molecules and polymers are carbon based, made using ...
Breaking Biology Technology:Involution Studios' Ebola Infographic Provides Key Disease Information and Statistics at a Glance 2Dr. Yousef Siddiqui joins the Grace Century Advisory Team 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 2Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 3
... may be on the rise, but solar cells are ... collect. Under the direction of a new professor at ... researchers have developed a new material that absorbs a ... efficient and less expensive solar technology. A paper ...
... a market leader in business transformation consulting, has appointed ... and Health Care Practice Group. In his new role, ... the Health Care and Life Science industry and be ... service offerings concentrating on alignment of organizational operations with ...
... In preparation for its European launch of Benlysta, the ... Genome Sciences (HGS) needed a customer relationship management (CRM) ... team. The company had a long list of selection ... speed, and low system maintenance. Veeva CRM - the ...
Cached Biology Technology:Solar power could get boost from new light absorption design 2Axia Value Chain Appoints John Christina Managing Director of Life Sciences Practice 2Human Genome Sciences Europe Moves to the Cloud With Veeva CRM to Support New Lupus Treatment 2Human Genome Sciences Europe Moves to the Cloud With Veeva CRM to Support New Lupus Treatment 3
(Date:10/25/2014)... This report covers the specifics of microRNA (miRNA) as ... of research due to its versatility and stability, properties ... components. miRNA,s non-coding nature and ability to affect genetic ... a biomarker for a variety of diseases. This prompted ... advancement in therapeutic development. Furthermore there are a number ...
(Date:10/22/2014)... Oct. 20, 2014  Leading identity analyst firm Acuity ... of the world,s population will have a chip-based National ... Europe . Asia , with ... accounting for more than 60% of all National eID ... report  -- "The Global National eID Industry ...
(Date:10/18/2014)... patients with undiagnosed, suspected genetic conditions, a certain type ... molecular diagnostic yield than traditional molecular diagnostic methods, according ... study is being released to coincide with the American ... which sequences the protein­coding region of the genome (the ... a cell or organism), has been rapidly applied in ...
Breaking Biology News(10 mins):MicroRNA: An Insight to miRNA-based microarrays, diagnostics and therapeutics Overview, Cambridge Healthtech Advisors 2Half the World's Population Will Have Chip-Based National Electronic Identity (eID) Cards by 2018 2Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3
... Researchers from the Polytechnic Institute of New York University ... National Institutes of Health (NIH) to further a novel ... cancer and diabetes. Jin Kim Montclare, associate ... Yingkai Zhang, associate professor of chemistry at NYU, have ...
... and Oxford, UK An advanced tumor is a complex ... it grows until it contains several subspecies of cells that ... heterogeneity is what makes advanced tumors so difficult to treat. ... Cell , an international team of scientists led jointly by ...
... now offering two more language-specific eBook collections, in French ... 330 titles, and the Italian collection offers over 400 ... aim to address the needs of the French- and ... accessing relevant scientific content from medicine, mathematics, computer science ...
Cached Biology News:National Institutes of Health to fund research probing proteins linked to cancer, diabetes 2Herding cancer cells to their death 2Herding cancer cells to their death 3Springer launches French- and Italian-language eBook collections 2